2018 ASCO-SITC Clinical Immuno-Oncology Symposium Public

Shridar Ganesan, MD, PhD, presenting Abstract 104, "Expression of endogenous retroviruses and response to immune checkpoint therapy in renal cell cancer," during Oral Abstract Session C: Biomarkers and Inflammatory Signatures

San Francisco, CA - 2018 Clinical Immuno-Oncology Symposium – Shridar Ganesan, MD, PhD, presenting Abstract 104, "Expression of endogenous retroviruses and response to immune checkpoint therapy in renal cell cancer," during Oral Abstract Session C: Biomarkers and Inflammatory Signatures at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium here today, Saturday, Jan. 27, 2018. The conference, which is a collaboration between the American Society of Clinical Oncology and Society for Immunotherapy of Cancer, is focused on clinical and translational research in immuno-oncology and the implications for clinical care. Photo by © ASCO/Scott Morgan 2018.